NCT05336968View on ClinicalTrials.gov

Triamcinolone Ketorolac (TriKe) Knee Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Triamcinolone acetonide-Ketorolac-Ropivacaine

Experimental for Osteoarthrosis of the Knee. One randomized injection to intraarticularly into affected knee at time of randomization

Trial Locations (1)

13850

RECRUITING

United Health Services Sports Medicine Department, Vestal

All Listed Sponsors
lead

United Health Services Hospitals, Inc.

OTHER